查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447713

远距患者监护市场：按产品、应用和最终用户划分——到 2031 年的全球预测

Remote Patient Monitoring Market by Product ( ) Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders) End User - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 247 Pages | 订单完成后即时交付

价格

预计到 2031 年，全球远距病患监护市场将达到 1,168.4 亿美元，2024 年至 2031 年的复合年增长率为 13.7%。

该报告基于全面的一手和二手研究以及对市场情景的详细分析，提供了该行业的关键驱动因素、限制因素、挑战和机会。 该市场的推动因素包括老年人口不断增长、慢性病患病率上升、医疗保健专业人员短缺、人们越来越认识到RPM 的好处（例如便利性和改善患者治疗效果）以及降低医疗成本的需求不断增长。驱动因素包括政府的有利措施促进远距患者监护。

此外，远距医疗和远距患者监护方面的技术进步、新兴国家患者数量的增加、可穿戴设备的日益普及、感测器技术的进步以及人工智慧和RPM 的整合正在推动该市场的显着增长。我们提供机会。 然而，对数据准确性和可靠性的担忧、限制远端患者监测技术使用的障碍（例如存取限制）以及患者技术素养较低正在限制市场成长。 此外，对资料安全和隐私的担忧，以及由于需要额外的人员来管理 RPM 系统而增加的管理成本，都对市场构成了挑战。

以产品来看，预计到2024年，监护设备领域将占据远距病患监护市场的最大份额。 此细分市场的重要份额是由于各种慢性病的盛行率不断上升、老年人口不断增加、有利的监管环境、感测器技术的技术进步、个人化医疗保健的需求不断增长、监测设备的人为增长。这是由于以下因素智能与机器学习的融合。

从应用来看，糖尿病领域预计将在 2024 年占据远端患者监测市场的最大份额。 传统上，糖尿病主要被认为是一种遗传性疾病，但其迅速流行使其被认为是一种与生活方式相关的疾病。 这个细分市场的很大一部分是由于远距医疗在糖尿病管理中的使用、糖尿病盛行率的增加以及监测糖尿病患者的需求增加等因素造成的。

从最终用户来看，家庭医疗保健领域预计将在 2024 年占据远距患者监护市场的最大份额。 该细分市场的巨大市场份额是由家庭护理环境的日益转变、老年人慢性病发病率的增加、医疗专业人员的短缺以及消费者对使用RPM工具监测慢性病的意识不断增强等推动的。

对全球远距病患监护市场区域状况的详细分析提供了五个关键区域的详细定性和定量见解。 到2024年，预计北美将占据全球远距病患监护市场的最大份额，其次是欧洲、亚太地区、拉丁美洲以及中东和非洲。 亚太地区预计将成为全球远距患者监护市场成长最快的地区。 这一增长主要是由医疗保健支出增加、老年人口不断增长、慢性病患病率上升、消费者意识提高、个人可支配收入增加以及更大的目标人群推动的，从而支持了市场成长。

目录

第1章简介

第2章研究方法

第 3 章执行摘要

第 4 章市场洞察

  • 市场
  • 摘要
  • 影响市场成长的因素
    • 市场动态影响分析
    • 因素分析
  • 远距病患监护市场的监管分析
    • 摘要
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东
  • 价格分析
  • 产业趋势
    • 医疗保健从医生主导转向消费者主导
    • 人工智慧与远距患者监护技术的集成
  • 波特五力分析

第 5 章远距病患监护市场评估：按产品

  • 摘要
  • 监控设备
    • 监控设备：依功能分类
    • 监控设备：依类型
  • 软体
  • 服务

第 6 章远距病患监护市场评估：按应用

  • 摘要
  • 糖尿病
  • 心血管疾病
  • 神经系统疾病
  • 呼吸系统疾病
  • 肿瘤学
  • 其他应用

第 7 章远距病患监护市场评估：按最终使用者划分

  • 摘要
  • 居家照护设施
  • 长期照护设施
  • 医院
  • 其他最终用户

第 8 章远距病患监护市场评估：按地区

  • 摘要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太地区其他地区
  • 拉丁美洲
  • 中东/非洲

第9章竞争分析

  • 摘要
  • 主要成长策略
  • 竞争基准测试
  • 竞争对手仪表板
    • 行业领导者
    • 市场差异化因素
    • 领先企业
    • 新兴公司

第10章公司简介

  • Medtronic plc
  • Koninklijke Philips N.V.
  • Omron Corporation
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Ge Healthcare Technologies, Inc.
  • F. Hoffmann-La Roche AG
  • Baxter International Inc.
  • Oracle Corporation
  • Dexcom, Inc.
  • VitalConnect, Inc.
  • Other Companies

第11章 附录

Product Code: MRHC - 104658

Remote Patient Monitoring Market by Product ([Blood Glucose, Respiratory, Blood Pressure, Fetal, Weight Monitoring] [Wearable, Portable, Benchtop]), Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders), End User-Global Forecast to 2031

The global remote patient monitoring market is projected to reach $116.84 billion by 2031, at a CAGR of 13.7% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, restraints, challenges, and opportunities of the industry. This market is driven by the increasing geriatric population, rising prevalence of chronic diseases, shortage of healthcare professionals, growing awareness regarding the benefits of RPM, such as convenience and improved patient outcomes, rising need to reduce healthcare costs, and favorable government initiatives promoting remote patient monitoring.

Furthermore, technological advancements in telehealth & remote patient monitoring, emerging economies with growing patient populations, increasing adoption of wearable devices, advancements in sensor technologies, and integration of artificial intelligence with RPM provide a significant growth opportunity for this market. However, data accuracy & reliability concerns, barriers limiting the use of remote patient monitoring technologies such as limited access, and low technology literacy among patients restrain the growth of the market. Additionally, data security & privacy concerns and increased overhead expenses due to the need for additional staff to manage the RPM system are challenging factors in the market.

Among products, in 2024, the monitoring devices segment is expected to account for the largest share of the remote patient monitoring market. The large share of this segment is attributed to factors such as the increasing prevalence of various chronic diseases, the rising elderly population, favorable regulatory scenarios, technological advancements in sensor technology, the rising demand for personalized healthcare, and the integration of artificial intelligence and machine learning in monitoring devices.

Among applications, in 2024, the diabetes segment is expected to account for the largest share of the remote patient monitoring market. Diabetes was traditionally viewed as a predominantly inherited disease but is increasingly recognized as a lifestyle-related condition due to its rapid prevalence. The large share of the segment is due to factors such as the utilization of telehealth during diabetes management, the increasing prevalence of diabetes, and the increased need to monitor diabetic patients.

Among end users, in 2024, the home-care settings segment is expected to account for the largest share of the remote patient monitoring market. This segment's large market share is attributed to the growing shift towards home-care settings, the rise in chronic diseases among the elderly, the shortage of healthcare professionals, and increasing consumer awareness regarding the monitoring of chronic conditions through RPM tools.

An in-depth analysis of the geographical scenario of the global remote patient monitoring market provides detailed qualitative and quantitative insights for the five major geographies: North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the global remote patient monitoring market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global remote patient monitoring market. This growth is primarily driven by the increasing healthcare expenditure, rising geriatric population, rising prevalence of chronic diseases, growing consumer awareness, increasing personal disposable incomes, and a large target population, thereby supporting the market growth.

The key players operating in the global remote patient monitoring market are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), GE HealthCare Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Baxter International, Inc. (U.S.), Oracle Corporation (U.S.), DexCom, Inc. (U.S.), and VitalConnect, Inc. (U.S.).

Scope of the Report:

Remote Patient Monitoring Market Assessment-by Product

  • Monitoring Devices
    • Monitoring Devices, by Functionality
  • Blood Glucose Monitoring Devices
  • Cardiac Monitoring Devices
  • Neurological Monitoring Devices
  • Respiratory Monitoring Devices
  • Multiparameter Monitoring Devices
  • Blood Pressure Monitoring Devices
  • Fetal and Neonatal Monitoring Devices
  • Weight Monitoring Devices
  • Other Monitoring Devices

Note: Other monitoring devices include temperature monitors, brain monitoring (EEG), and prothrombin monitors.

    • Monitoring Devices, by Type
  • Wearable Monitoring Devices
  • Portable Monitoring Devices
  • Bench-top Monitoring Devices
  • Software
  • Services

Remote Patient Monitoring Market Assessment-by Application

  • Diabetes
  • Cardiovascular Diseases
  • Neurological Diseases
  • Respiratory Diseases
  • Oncology
  • Other Applications

Note: Other applications include maternity care, post-surgery monitoring, elderly care, medical adherence, and sleep monitoring.

Remote Patient Monitoring Market Assessment-by End User

  • Home-care Settings
  • Hospitals
  • Long-term Care Facilities
  • Other End Users

Note: Other end users include ambulatory care, healthcare payers, and clinical research organizations

Remote Patient Monitoring Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition And Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency And Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection And Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research / Interviews With Key Opinion Leaders of The Industry
  • 2.3. Market Sizing And Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions For The Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Remote Patient Monitoring Market: Regulatory Analysis
    • 4.3.1. Overview
    • 4.3.2. North America
      • 4.3.2.1. U.S.
      • 4.3.2.2. Canada
    • 4.3.3. Europe
    • 4.3.4. Asia-Pacific
      • 4.3.4.1. China
      • 4.3.4.2. Japan
      • 4.3.4.3. India
    • 4.3.5. Latin America
    • 4.3.6. Middle East
  • 4.4. Pricing Analysis
  • 4.5. Industry Trends
    • 4.5.1. Shift From Physician-Driven to Consumer-Driven Healthcare
    • 4.5.2. Integration of Artificial Intelligence With Remote Patient Monitoring Technologies
  • 4.6. Porter's Five Forces Analysis
    • 4.6.1. Bargaining Power of Buyers
    • 4.6.2. Bargaining Power of Suppliers
    • 4.6.3. Threat of Substitutes
    • 4.6.4. Threat of New Entrants
    • 4.6.5. Degree of Competition

5. Remote Patient Monitoring Market Assessment- by Product

  • 5.1. Overview
  • 5.2. Monitoring Devices
    • 5.2.1. Monitoring Devices, by Functionality
      • 5.2.1.1. Blood Glucose Monitoring Devices
      • 5.2.1.2. Cardiac Monitoring Devices
      • 5.2.1.3. Neurological Monitoring Devices
      • 5.2.1.4. Respiratory Monitoring Devices
      • 5.2.1.5. Multiparameter Monitoring Devices
      • 5.2.1.6. Blood Pressure Monitoring Devices
      • 5.2.1.7. Fetal And Neonatal Monitoring Devices
      • 5.2.1.8. Weight Monitoring Devices
      • 5.2.1.9. Other Monitoring Devices
    • 5.2.2. Monitoring Devices, by Type
      • 5.2.2.1. Wearable Monitoring Devices
      • 5.2.2.2. Portable Monitoring Devices
      • 5.2.2.3. Bench-Top Monitoring Devices
  • 5.3. Software
  • 5.4. Services

6. Remote Patient Monitoring Market Assessment-by Application

  • 6.1. Overview
  • 6.2. Diabetes
  • 6.3. Cardiovascular Diseases
  • 6.4. Neurological Disorders
  • 6.5. Respiratory Diseases
  • 6.6. Oncology
  • 6.7. Other Applications

7. Remote Patient Monitoring Market Assessment-by End User

  • 7.1. Overview
  • 7.2. Home-Care Settings
  • 7.3. Long-Term Care Facilities
  • 7.4. Hospitals
  • 7.5. Other End Users

8. Remote Patient Monitoring Market Assessment-by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. U.K.
    • 8.3.3. France
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Rest of Asia-Pacific
  • 8.5. Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies

10. Company Profiles

  • 10.1. Medtronic plc
  • 10.2. Koninklijke Philips N.V.
  • 10.3. Omron Corporation
  • 10.4. Boston Scientific Corporation
  • 10.5. Abbott Laboratories
  • 10.6. Siemens Healthineers AG
  • 10.7. Ge Healthcare Technologies, Inc.
  • 10.8. F. Hoffmann-La Roche AG
  • 10.9. Baxter International Inc.
  • 10.10. Oracle Corporation
  • 10.11. Dexcom, Inc.
  • 10.12. VitalConnect, Inc.
  • 10.13. Other Companies

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports
  • Table 1 Population Aged 65 or Above, by Region, 2019 Vs. 2030 Vs. 2050 (In Million)
  • Table 2 Total Deaths Due to Parkinson's And Alzheimer's, by Country, 2010 Vs. 2019 Vs. 2020
  • Table 3 Total Deaths Due to Respiratory Disorders (Influenza, Pneumonia, COPD, Asthma), by Country, 2010 Vs. 2019 Vs. 2020
  • Table 4 Total Deaths Due to Circulatory System Diseases (Ischemic Heart Disease, Cerebrovascular Diseases), by Country, 2010 Vs. 2019 Vs. 2020
  • Table 5 Recent Technological Developments in Remote Patient Monitoring
  • Table 6 Physicians Per 1000 People, by Country, 2020
  • Table 7 Hospital Beds Per 1000 People, by Country, 2020
  • Table 8 Remote Patient Monitoring Devices: FDA Medical Device Classification
  • Table 9 China's Medical Device Classification Management System
  • Table 10 Saudi Arabia: Medical Device Classification System
  • Table 11 Remote Patient Monitoring Devices: Pricing Analysis
  • Table 12 Remote Patient Monitoring Services: Pricing Model
  • Table 13 Global Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 14 Global Remote Patient Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global Remote Patient Monitoring Devices Market, by Functionality, 2022-2031 (USD Million)
  • Table 16 Number of People With Diabetes, by Region (2021 Vs. 2030) (In Thousands)
  • Table 17 Global Blood Glucose Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Some of The Examples of Wearable Cardiac Monitoring Devices
  • Table 19 Some of The Examples of Implantable Cardiac Monitoring Devices
  • Table 20 Global Cardiac Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 21 Global Neurological Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Respiratory Monitoring Devices, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Global Multiparameter Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 24 Global Blood Pressure Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 25 Number of Childbirths Per Year (2020 Vs. 2030)
  • Table 26 Global Fetal And Neonatal Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 27 Global Weight Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 28 Global Other Remote Patient Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 29 Global Remote Patient Monitoring Devices, by Type, 2022-2031 (USD Million)
  • Table 30 Innovative Wearable Remote Patient Monitoring Devices
  • Table 31 Global Wearable Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Portable Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 33 Global Bench-Top Remote Patient Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 34 Major Features of Remote Patient Monitoring Software
  • Table 35 Global Remote Patient Monitoring Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Types of Services Involved in Remote Patient Monitoring
  • Table 37 Trends in The Services Segment
  • Table 38 Global Remote Patient Monitoring Services Market, by Country/Region, 2022-2031 (USD Million)
  • Table 39 Global Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 40 Some of The Companies Offering Remote Patient Monitoring For Diabetes
  • Table 41 Global Remote Patient Monitoring Market For Diabetes, by Country/Region, 2022-2031 (USD Million)
  • Table 42 Some of The Companies Offering Remote Patient Monitoring For Cardiovascular Diseases
  • Table 43 Global Remote Patient Monitoring Market For Cardiovascular Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 44 Burden of Neurological Conditions (Dalys Per 100,000 Population)
  • Table 45 Deaths Per 100,000 Population Due to Parkinson's Disease And Alzheimer
  • Table 46 Some of The Companies Offering Remote Patient Monitoring For Neurological Disorders
  • Table 47 Global Remote Patient Monitoring Market For Neurological Disorders, by Country/Region, 2022-2031 (USD Million)
  • Table 48 Some of The Companies Offering Remote Patient Monitoring For Respiratory Diseases
  • Table 49 Global Remote Patient Monitoring Market For Respiratory Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 50 Some of The Companies Offering Remote Patient Monitoring For Oncology
  • Table 51 Global Remote Patient Monitoring Market For Cancer, by Country/Region, 2022-2031 (USD Million)
  • Table 52 Some of The Companies Offering Remote Patient Monitoring For Other Applications
  • Table 53 Global Remote Patient Monitoring Market For Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 54 Global Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 55 Global Remote Patient Monitoring Market For Home-Care Settings, by Country/Region, 2022-2031 (USD Million)
  • Table 56 Global Remote Patient Monitoring Market For Long-Term Care Facilities, by Country/Region, 2022-2031 (USD Million)
  • Table 57 Global Remote Patient Monitoring Market For Hospitals, by Country/Region, 2022-2031 (USD Million)
  • Table 58 Global Remote Patient Monitoring Market For Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 59 Global Remote Patient Monitoring Market, by Country/Region, 2022-2031 (USD Million)
  • Table 60 North America: Remote Patient Monitoring Market, by Country, 2022-2031 (USD Million)
  • Table 61 North America: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 62 North America: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 63 North America: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 64 North America: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 65 North America: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 66 U.S.: Macro Indicators & Micro Indicators
  • Table 67 U.S.: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 68 U.S.: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 69 U.S.: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 70 U.S.: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 71 U.S.: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 72 Canada: Macroeconomic Indicators
  • Table 73 Canada: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 74 Canada: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 75 Canada: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 76 Canada: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 77 Canada: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 78 Europe: Remote Patient Monitoring Market, by Country/Region, 2022-2031 (USD Million)
  • Table 79 Europe: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 80 Europe: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 81 Europe: Remote Patient Monitoring Market, by Type, 2022-2031 (USD Million)
  • Table 82 Europe: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 83 Europe: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 84 Germany: Macroeconomic Indicators
  • Table 85 Germany: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 86 Germany: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 87 Germany: Remote Patient Monitoring Devices, by Type, 2022-2031 (USD Million)
  • Table 88 Germany: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 89 Germany: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 90 U.K.: Prevalence of Various Chronic Conditions
  • Table 91 U.K.: Macroeconomic Indicators
  • Table 92 U.K.: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 93 U.K.: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 94 U.K.: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 95 U.K.: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 96 U.K.: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 97 France: Macroeconomic Indicators
  • Table 98 France: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 99 France: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 100 France: Remote Patient Monitoring Market, by Type, 2022-2031 (USD Million)
  • Table 101 France: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 102 France: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 103 Italy: Leading Causes of Deaths (2020)
  • Table 104 Italy: Macroeconomic Indicators
  • Table 105 Italy: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 106 Italy: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 107 Italy: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 108 Italy: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 109 Italy: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 110 Spain: Macroeconomic Indicators
  • Table 111 Spain: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 112 Spain: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 113 Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 114 Spain: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 115 Spain: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 116 Rest of Europe: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 117 Rest of Europe: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 118 Rest of Europe: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 119 Rest of Europe: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 120 Rest of Europe: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 121 Asia-Pacific: Remote Patient Monitoring Market, by Country/Region, 2022-2031 (USD Million)
  • Table 122 Asia-Pacific: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 123 Asia-Pacific: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 124 Asia-Pacific: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 125 Asia-Pacific: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 126 Asia-Pacific: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 127 China: Macroeconomic Indicators
  • Table 128 China: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 129 China: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 130 China: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 131 China: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 132 China: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 133 Japan: Macroeconomic Indicators
  • Table 134 Japan: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 135 Japan: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 136 Japan: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 137 Japan: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 138 Japan: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 139 India: Macroeconomic Indicators
  • Table 140 India: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 141 India: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 142 India: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 143 India: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 144 India: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 145 Rest of Asia-Pacific: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 146 Rest of Asia-Pacific: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 147 Rest of Asia-Pacific: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 148 Rest of Asia-Pacific: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 149 Rest of Asia-Pacific: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 150 Latin America: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 151 Latin America: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 152 Latin America: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 153 Latin America: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 154 Latin America: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 155 Middle East & Africa: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 156 Middle East & Africa: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 157 Middle East & Africa: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 158 Middle East & Africa: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 159 Middle East & Africa: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 160 Recent Developments, by Company, 2020-2024
  • Table 161 Product Portfolio Analysis

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for This Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Remote Patient Monitoring Market Size, by Product, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global Remote Patient Monitoring Market Size, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Remote Patient Monitoring Market Size, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 10 Remote Patient Monitoring Market, by Geography
  • Figure 11 Impact Analysis of Market Dynamics
  • Figure 12 Global Estimated Number of New Cancer Cases, 2020-2040
  • Figure 13 Benefits of Remote Patient Monitoring
  • Figure 14 Global Prevalence of Diabetes in People Aged 20-79 Years, 2011-2045
  • Figure 15 USFDA Regulatory Pathways For Medical Devices
  • Figure 16 Eu Regulatory Pathway - IVDR 2017/746
  • Figure 17 China: Medical Device Classification And Pre-Market Requirements For IVD Devices
  • Figure 18 Advantages of AI Integration in Remote Patient Monitoring
  • Figure 19 Porter's Five Forces Analysis
  • Figure 20 Global Remote Patient Monitoring Market, by Product, 2024 Vs. 2031 (USD Million)
  • Figure 21 Global Remote Patient Monitoring Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 22 Estimated Number of Cancer Cases (2020-2040)
  • Figure 23 Global Remote Patient Monitoring Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 24 Global Remote Patient Monitoring Market, by Geography, 2024 Vs. 2031 (USD Million)
  • Figure 25 North America: Remote Patient Monitoring Market Snapshot
  • Figure 26 Geriatric Population in Canada (2019-2050)
  • Figure 27 Europe: Remote Patient Monitoring Market Snapshot
  • Figure 28 Asia-Pacific: Remote Patient Monitoring Market Snapshot
  • Figure 29 China: Estimated Number of New Cancer Cases (2020-2040)
  • Figure 30 Japan: Percentage of Population Aged 65 And Above (2010-2030)
  • Figure 31 Key Growth Strategies Adopted by Leading Players, 2020-2023
  • Figure 32 Remote Patient Monitoring Market: Competitive Benchmarking by Region
  • Figure 33 Competitive Dashboard: Remote Patient Monitoring Market
  • Figure 34 Medtronic plc: Financial Overview (2022)
  • Figure 35 Koninklijke Philips N.V.: Financial Overview (2022)
  • Figure 36 OMRON Corporation: Financial Overview (2022)
  • Figure 37 Boston Scientific Corporation: Financial Overview (2022)
  • Figure 38 Abbott Laboratories: Financial Overview (2022)
  • Figure 39 Siemens Healthineers AG: Financial Overview (2022)
  • Figure 40 GE Healthcare Technologies, Inc.: Financial Overview (2023)
  • Figure 41 F. Hoffmann-La Roche AG: Financial Overview (2023)
  • Figure 42 Baxter International, Inc.: Financial Overview (2023)
  • Figure 43 Oracle Corporation: Financial Overview (2022)
  • Figure 44 DexCom, Inc.: Financial Overview (2023)